Cashflow loss for FY and cash flow funding available are 2 different things. The former is receipts less costs while the latter is a reflection of how long the cash balance can sustain a quarterly receipt to cost deficit. The bleeding is still there, and they have done well to reduce the level of bleeding but more needs to be done to make it sustainable. IMO.
Ann: Annual Report to Shareholders, page-4
Add AEI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.3¢ |
Change
-0.003(4.55%) |
Mkt cap ! $15.47M | |||
| Open | High | Low | Value | Volume |
| 6.5¢ | 6.6¢ | 6.3¢ | $10.07K | 157.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 80645 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.6¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.6¢ |
Change
-0.003 ( 1.54 %) |
||||
| Open | High | Low | Volume | ||
| 6.4¢ | 6.6¢ | 6.3¢ | 46497 | ||
| Last updated 15.38pm 14/05/2024 ? | |||||
| AEI (ASX) Chart |